UPDATE : Friday, July 10, 2020
Pharma shares on the rise since early this year by Nam Doo-hyun 2018-04-25 13:56
NIBEC wins anti-cancer peptide patent in the US by Lee Han-soo 2018-04-23 15:15
Kolon unveils trial results for Invossa at cartilage repair conference by Lee Han-soo 2018-04-20 15:57
Blockbuster Remicade losing out to Korean biosimilars in US by So Jae-hyeon 2018-04-19 15:39
Hanmi gets FDA nod for nonalcoholic steatohepatitis treatment trials by Lee Han-soo 2018-04-19 15:29
Biotech stocks could be overpriced: analysts by Nam Doo-hyun 2018-04-19 13:34
Pharmbio to market Shionogi’s dyspareunia treatment by Lee Han-soo 2018-04-18 14:10
ViroMed confirms VM202’s pain control in animal test by Nam Doo-hyun 2018-04-18 11:39
‘Genexine’s pipelines worth more than ₩3 trillion’ by Nam Doo-hyun 2018-04-16 15:48
Daewoong opens biotech research lab in Indonesia by So Jae-hyeon 2018-04-12 11:37
Biotech CEOs roll up sleeves for global biz by So Jae-hyeon 2018-04-10 12:09
Samsung Bioepis settles patent disputes with AbbVie on Humira by Lee Han-soo 2018-04-06 15:21
CTC Bio gets sales nod for erectile dysfunction treatment in Vietnam by Lee Han-soo 2018-04-04 10:59
Steelmaker POSCO to challenge biotech sector by So Jae-hyeon 2018-04-03 11:58
Toolgen to develop hepatitis B treatment by Lee Han-soo 2018-03-30 17:28
Kangstem Biotech wins patent on neural stem cells by Lee Han-soo 2018-03-29 17:12
Huons wins sales approval for hyaluronic acid filler in Indonesia by Lee Han-soo 2018-03-29 15:10
Stem cell therapy developers unaffected by Cha Biotech debacle by Nam Doo-hyun 2018-03-26 15:58
KRX names CHA Biotech as administrative issue, leading to 30% stock fall by Marian Chu, Lee Han-soo 2018-03-23 15:16
Foreigners buy SillaJen, Samsung BioLogics, dump Celltrion by Nam Doo-hyun 2018-03-20 12:01
Back to Top